[Precise immunological classification guidance for early initiation of antiviral therapy in patients with chronic HBV infection].

Zhao, S X; Chang, C D; Nan, Y M

Zhao, S X; Chang, C D; Nan, Y M.

Afiliação

Zhao SX; Department of Traditional and Western Medical Hepatology, the Third Hospital of Hebei Medical University, the Key Laboratory of Hepatic Fibrosis Mechanisms of Chronic Liver Diseases in Hebei Province, Shijiazhuang 050051, China.
Chang CD; Department of Traditional and Western Medical Hepatology, the Third Hospital of Hebei Medical University, the Key Laboratory of Hepatic Fibrosis Mechanisms of Chronic Liver Diseases in Hebei Province, Shijiazhuang 050051, China.
Nan YM; Department of Traditional and Western Medical Hepatology, the Third Hospital of Hebei Medical University, the Key Laboratory of Hepatic Fibrosis Mechanisms of Chronic Liver Diseases in Hebei Province, Shijiazhuang 050051, China.

Zhonghua Gan Zang Bing Za Zhi ; 31(3): 228-232, 2023 Mar 20.

Article em Zh | MEDLINE | ID: mdl-37137845

Assuntos

Hepatite B Crônica; Humanos; Vírus da Hepatite B; Antígenos de Superfície da Hepatite B; Antivirais/uso terapêutico; Interferon-alfa/uso terapêutico

Palavras-chave

Antiviral therapy; Hepatitis B virus; Immunology; Infection; Phases

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite B Crônica Tipo de estudo: Guideline Limite: Humans Idioma: Zh Revista: Zhonghua Gan Zang Bing Za Zhi Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google